Do patients with basilar or vertebral artery stenosis have a higher stroke incidence poststenting?

被引:24
作者
Jiang, W-J [1 ]
Du, B. [1 ]
Hon, S. F. K. [2 ]
Jin, M. [1 ]
Xu, X-T [3 ]
Ma, N. [1 ]
Gao, F. [1 ]
Dong, K-H [4 ]
机构
[1] Capital Med Univ, Beijing Tiantan Hosp, Dept Intervent Neuroradiol, Beijing 100050, Peoples R China
[2] Queen Mary Hosp, Dept Med, Neurol Team, Hong Kong, Hong Kong, Peoples R China
[3] Capital Med Univ, Beijing Tiantan Hosp, Dept Radiol, Beijing 100050, Peoples R China
[4] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing 100050, Peoples R China
关键词
INTRACRANIAL ATHEROMATOUS DISEASE; STENT-ASSISTED ANGIOPLASTY; VERTEBROBASILAR STENOSIS; INITIAL-EXPERIENCE; WINGSPAN STENT; MULTICENTER; SAFETY; SYSTEM;
D O I
10.1136/jnis.2009.000356
中图分类号
R445 [影像诊断学];
学科分类号
100207 ;
摘要
Background and aim Posterior circulation stenosis may be a risk factor associated with stroke after intracranial stenting as compared with anterior circulation stenosis. Our aim was to test our hypothesis that there was no difference in clinical outcome poststenting between patients with severe stenosis of the basilar artery (BA) and intracranial vertebral artery (VA). Methods Using the Cox proportional hazards regression model adjusted for prespecified factors (qualifying event, and timing of stenting after the qualifying event), we compared primary endpoint (ischemic stroke in the vertebrobasilar territory, including any stroke or death within 30 days of stenting) between patients with severe symptomatic atherosclerotic BA and VA stenosis who underwent elective stenting in our prospective database. Analysis was by intention-to-treat principle. Results Primary endpoint event occurred in 13 (18.8%) of 69 patients with BA stenosis during a mean 23.4 months (9 within 30 days and 4 afterward) and 3 (4.3%) of 70 patients with VA stenosis during a mean 26.4 months (2 within 30 days and 1 afterward). Patients with BA stenosis had a significantly higher risk of the primary endpoint (adjusted HR = 4.87, 95% CI 1.37 to 17.29; p = 0.014) or any stroke or death within 30 days of stenting (adjusted HR = 5.13, 95% CI 1.10 to 23.96; p = 0.038) than those with VA stenosis. Conclusion A significantly higher stroke risk poststenting exists in patients with severe BA stenosis than those with VA stenosis. The discrepancy in clinical outcome after stenting between patients with BA and VA stenosis should be considered in clinical practice and stenting trials.
引用
收藏
页码:50 / 54
页数:5
相关论文
共 27 条
[1]   A novel, self-expanding, nitinol stent in medically refractory intracranial atherosclerotic stenoses - The Wingspan study [J].
Bose, Arani ;
Hartmann, Marius ;
Henkes, Hans ;
Liu, Hon Man ;
Teng, Michael M. H. ;
Szikora, Istvan ;
Berlis, Ansgar ;
Reul, Jurgen ;
Yu, Simon C. H. ;
Forsting, Michael ;
Lui, Matt ;
Lim, Winston ;
Sit, Siu Po .
STROKE, 2007, 38 (05) :1531-1537
[2]   Preliminary evidence supporting the safety of drug-eluting stents in neurovascular disease [J].
Boulos, AS ;
Agner, C ;
Deshaies, EM .
NEUROLOGICAL RESEARCH, 2005, 27 :S95-S102
[3]   Prognosis of patients with symptomatic vertebral or basilar artery stenosis [J].
Chimowitz, MI ;
Strong, J ;
Brown, MB ;
Perkins, A ;
Liang, WM ;
Yang, I ;
Kokkinos, J ;
Levine, SR ;
Silliman, S ;
Pessin, MS ;
Caplan, LR ;
Weichel, E ;
Sila, CA ;
Furlan, AJ ;
Dyko, B ;
Kargman, DE ;
Sacco, RL ;
Wityk, RJ ;
Stern, BJ ;
Agbogu, B ;
Jain, M ;
Ford, G ;
Fayad, PB .
STROKE, 1998, 29 (07) :1389-1392
[4]   Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis [J].
Chimowitz, MI ;
Lynn, MJ ;
Howlett-Smith, H ;
Stern, BJ ;
Hertzberg, VS ;
Frankel, MR ;
Levine, SR ;
Chaturvedi, S ;
Kasner, SE ;
Benesch, CG ;
Sila, CA ;
Jovin, TG ;
Romano, JG .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (13) :1305-1316
[5]   Recurrent symptomatic high-grade intracranial stenoses: Safety and efficacy of undersized stents - Initial experience [J].
de Rochemont, RD ;
Turowski, B ;
Buchkremer, M ;
Sitzer, M ;
Zanella, FE ;
Berkefeld, J .
RADIOLOGY, 2004, 231 (01) :45-49
[6]   A 7-year experience with balloon-mounted coronary stents for the treatment of symptomatic vertebrobasilar intracranial atheromatous disease [J].
Fiorella, David ;
Chow, Michael M. ;
Anderson, Michael ;
Woo, Henry ;
Rasmussen, Peter A. ;
Masaryk, Thomas J. .
NEUROSURGERY, 2007, 61 (02) :236-242
[7]   US multicenter experience with the wingspan stent system for the treatment of intracranial atheromatous disease - Periprocedural results [J].
Fiorella, David ;
Levy, Elad I. ;
Turk, Aquilla S. ;
Albuquerque, Felipe C. ;
Niemann, David B. ;
Aagaard-Kienitz, Beverly ;
Hanel, Ricardo A. ;
Woo, Henry ;
Rasmussen, Peter A. ;
Hopkins, L. Nelson ;
Masaryk, Thomas J. ;
McDougall, Cameron G. .
STROKE, 2007, 38 (03) :881-887
[8]   Elective stenting of symptomatic basilar artery stenosis [J].
Gomez, CR ;
Misra, VK ;
Liu, MW ;
Wadlington, VR ;
Terry, JB ;
Tulyapronchote, R ;
Campbell, MS .
STROKE, 2000, 31 (01) :95-99
[9]   A Systematic Review on Outcome After Stenting for Intracranial Atherosclerosis [J].
Groeschel, Klaus ;
Schnaudigel, Sonja ;
Pilgram, Sara M. ;
Wasser, Katrin ;
Kastrup, Andreas .
STROKE, 2009, 40 (05) :E340-E347
[10]  
Hatano T, 2005, ACTA NEUROCHIR SUPPL, V94, P137